Revised as of July 25, 2023
Yonago Acta Medica Editorial Committee
Tottori University Medical Press
Yonago, Japan

Yonago Acta Medica
Instructions for Authors 2023
Contents
P 2 Overview

Manuscript Style
P3
P3
P3
P3
P3
P4
P5
P5
P5
P6
P6
P6
P7
P8

§1
§2
§3

Paper
FormatManuscript Structure

§4
§5
§6
§7
§8
§9

Title page
Abstract page
Text pages
Acknowledgments
Conflict of interest
References

§10
§11
§12
§13
§14

TablesLegends for figures
FiguresAbbreviations
E-text and online submission

Appendices
P9
P9
P9
P 10
P 10
P 11
P14
P14

Table 1. List of abbreviations
Table 2. SI prefixes, symbols & factors
Table 3. SI and related units
Table 4. Statistical symbols
Table 5. Japanese selections from the list of journal indexed for PubMed users
International Committee of Medical Journal Editors (ICMJE) Uniform Requirements
for Manuscripts (URM) Submitted to Biomedical Journals: Sample references
ICMJE Form for Disclosure of Potential Conflicts of Interest (Abstract form)
Code of Ethics

YAM Instructions for Authors

Overview
1)

Yonago Acta Medica is published four times a year by the Tottori University Medical Press. As a general rule,its contributors are limited to researchers of the Tottori University and the Tottori University Hospital. However,researchers from outside the university community mentioned above may also submit papers, provided they receive a
recommendation from professors, associate professors, junior associate professors within the university, or membersof the Editorial Committee of Yonago Acta Medica. The subject areas encompass the following fields: molecular/cellbiology, biochemistry, basic medicine, clinical medicine, veterinary medicine, clinical nutrition and food sciences,medical engineering, nursing sciences, laboratory medicine, clinical psychology, and medical education.

2)

Deadlines for submissions and publication months are as follows:
Issue Scheduled publication month Submission period
1

February

2

May

All year round（Excludes thesis intended
for degree application*）
August		3
4
3)

November*A deadline has already been set for thethesis for the doctoral degree application.
For the deadline information, please refer tothe campus e-mail regarding the submission
process, which is delivered by the editorial
office, or contact us directly.

Manuscripts must not have been previously published by another journal. Do not submit any manuscript scheduled
for publication or currently submitted to a different publisher. Works published in our journal (including manuscripts
currently submitted for review) may not be reproduced in other publications without our authorization.

4)

For our code of ethics, please see page 14.

5)

Contributors must conduct a self-check for the status of conflicts of interest (COI) regarding the paper via the “Formfor Disclosure of Potential Conflicts of Interest,” provided by International Committee of Medical Journal Editors(ICMJE). The form can be accessed and downloaded through the following link:			 http://www.icmje.org/conflicts-of-interest/
			 For an abstract of the form, see page 14. If, after verification, it is confirmed that there are no conflicts of interest in
all the question items, please state the result in your cover letter. If, on the other hand, any conflicts of interest arefound, this should also be stated in the cover letter and the completed above-mentioned form should be additionallysubmitted to Yonago Acta Medica.
6)

Articles should be proofread by native speakers of English before submission. Diagram titles and legends, as well as
any other text, also need to be proofread.

7)

Manuscripts should be submitted in digital format to the editorial office. The submission form and a cover letter
addressed to the editor-in-chief, in which the new findings of the paper are detailed, must be submitted as well. Those
documents may be attached to an e-mail or submitted through a portable medium such as a compact disc or a USB
flash drive.

8)

Papers are categorized as follows: review articles (up to 6,000 words), original articles (up to 5,000 words), patientreports (up to 4,000 words), and short communications (up to 1,200 words.) Text in abstracts, references, anddiagrams is not included in the word count. Short communications should not include more than one figure and one
table, respectively.

9)

Following peer review and revision, the final version of manuscripts will be submitted to an English-language editor
designated by the editorial committee.

10)

The copyrights and publication rights (including online publication) of the manuscripts belong to the Tottori
University Medical Press. The management of the copyrights of Yonago Acta Medica is entrusted to the Japan
Academic Association For Copyright Clearance (JAC). Administration fees of JAC shall be deducted from theroyalties and the remainder shall be considered the revenue of the Tottori University Medical Press. To consent tothese terms, contributors must sign the copyright transfer document (page 2 of the submission form). All co-authors

page 2

must also sign the form.

YAM T.
Instructions
Authors
Suzuki etforal.,
P. 3

11)

As a general rule, proofreading is limited to two times and is performed within 48 hours. Do not make corrections
to the manuscript at the proofreading stage.

12)

Necessary expenses will be charged.

13)

In the case of theses intended for Ph.D. degree application, the supervisor for the applicant should affix his/her sealon the top right of the submission form. Administrative information should be entered on the submission form. The
form can be found on and downloaded from the Tottori University Medical Library site. (http://www.lib.tottori-u.
ac.jp/yam/file5-1.html)§ 1 Paper

Manuscript Style
原稿の様式

1) A4 or Letter size.
2) 2.5 cm margin on all sides．
3) About 60 characters per line and 25 to 27 lines and about 300 words per page is standard. The number of words per
page may be increased.
4) Pagination must be included in the upper right corner from page 2. Refer to the header style of this page.
§ 2 Format
1) Use 10 or 12 point font．
2) Type in the European typing style. Fonts such as Times New Roman, Arial, etc. are preferable.				
*Do not use Japanese fonts, including symbols.
§ 3 Manuscript Structure
For original articles, follow the structure below. Insert a page break after each section and add pagination.
1) Title page→§ 42) ABSTRACT, Key words→§ 53) TEXT→§ 64) Acknowledgments→§ 75) Conflict of interest→§ 86) REFERENCES→§ 97) Tables→ § 108) Legends for figures→ § 11
9) Figures→ § 12§ 4 Title page
Follow the structure below．
1) Title. For subtitles, insert a colon after the title and type on the same line. (Do not use a dash.)
2) Author. Type full names as in the following example. (Do not include degrees, titles, etc.)			
			
Ex: Taro Tottori, Hanako Yonago and Jiro Kurayoshi
3) Affiliation. If different authors have different affiliations, use footnote symbols in the following order for each.

*, †, ‡, §, ||, ¶, **, ††, ‡‡, §§, ||||, ¶¶, . . .
Write organization names, city names, and postal codes. Do not include street numbers and prefectures.
[Example]
Taro Yamada* and Jiro Suzuki†*Division of Surgical Oncology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine,
Yonago 683-8503, Japan and †Division of Organ Pathology, Department of Pathology, School of Medicine, Tottori
University Faculty of Medicine, Yonago 683-8503, Japan
4) Corresponding author. Next to the full name, write titles (MD, PhD, etc.) and e-mail addresses.
5) Running title. Must be within 50 characters.
*Abbreviations (including author-specific terms) may be used. First letter should be capitalized.
6) Abbreviations. List of abbreviations used by the author. (See p. 8, section 13.5 for reference)

page 3

YAM Instructions for Authors

5.1 ABSTRACT
1) Original articles should use the "structured abstract" format (Divided according to the following structure: Background,
Methods, Results, Conclusion.) For other categorized articles, use the "one paragraph" structure．
2) Short communications should be no longer than 150 words. Others should be no longer than 300 words.
3) Abbreviations and scientific notation should be avoided as much as possible in abstracts.
4) Do not directly cite diagrams or references.
5.2 Key words
1) Arrange up to 5 items in alphabetical order without using abbreviations and separate them with semicolons (;). Use lower-				case letters (except for proper nouns and proper adjectives).

		[Example]: Key words: electrooculography; magnetic resonance imaging; streptozotocin

2) Keywords should be selected from MEDLINE/Pubmed entries and/or Medical Subject Headings (MeSH). To check the 					

MeSH terms, go to PubMed and search the MeSH Database. If using italic or Greek characters, review and align with the 				

MeSH style recommendations. Also consult MeSH for keyword superscripts/subscripts.

PubMed Services>
MeSH Database [to find MeSH Terms]
www.ncbi.nlm.nih.gov/entrez/query.fcgi > www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=mesh
MeSH is NLM’s controlled vocabulary used for indexing articles for MEDLINE/PubMed [NLM =United States’ National Library of Medicine]★ A dedicated link to PubMed for Tottori University can be found on the Tottori University Library site. (http://www.lib.tottori-u.ac.jp/medical.html/)§ 6 Text pages

6.1 Text structure
For original articles, follow the structure below.
1) INTRODUCTION*Do not use headings for introductions.

2) MATERIALS AND METHODS (SUBJECTS AND METHODS or EXPERIMENTAL PROCEDURES are also acceptable.)3) RESULTS
4) DISCUSSION (or RESULTS AND DISCUSSION)

For patient reports, follow the structure below.
1) INTRODUCTION *Do not use headings for introductions.
2) PATIENT REPORT3) (DISCUSSION) *There may not be a discussion section.
6.2 Subheading
Divide MATERIALS AND METHODS and RESULTS into sections with subheadings. Do not number the subheadings. In 			
the DISCUSSION, keep the text concise without dividing it into sections.
6.3 Style guide1) Alignment
		 Do not justify text on the right.
2) Space		 Within the text, leave a half-width space between words, between numbers and units, after punctuation, etc.
			
*Exceptions*: % and ˚ (angles) should be typed without space next to the number.
3) Hyphensa. Do not split words at the end of a line. Exception: antib. Latin terms used as adjectives should not be hyphenated.
Example: in vitro methods; post hoc hypothesisc. Use an en-dash (–) to express range. There should be no space between the en-dash and the values.
Example: 5–10 mL; 200–800 pg/mL
d. Use an en-dash (–) for the minus symbol.

page 4

YAM Instructions for Authors

4) Numbers
a. Use Arabic numerals before units.
b. When a number appears at the beginning of a sentence, spell both numbers and units. Do not start sentences with Arabic
numerals. Figure descriptions may start with Arabic numerals.
c. As a general rule, numbers are represented using Arabic numerals. However, we respect the style of the author for		 number use. Take care not to mix Arabic numerals and spelled numbers.
Example："1 patient" and "one patient" should not be mixed.
d. For numbered enumeration within the text, use lower-case roman numerals. Roman numerals combine the letters i, v, x, etc.			
[Example]: i); ii); ... iv); v); ... ix); x) ....
5) Brackets
a. Bracket types should be used in this order: {. . . [. . .(. . .). . .]. . .}. The same type should not be used twice in a row.
Incorrect example: (. . . (. . .). . .)b. Quotations in parentheses should be preceded and followed by a space.
c. There should be no spaces between the opening and closing parentheses and the text they frame.
				[Example]： (Fig. 1)(P < 0.05)(Smith et al., 2011)

6) Italica. Scientific names should be italicized.
b. Latin words other than scientific names should not be italicized.			
Example: in vivo, et al., etc.
7) Country names
		 As a general rule, abbreviated names are not used. When the name of a country is long and the abbreviation is well 					known, it may be used.
8) Citation of chemicals, instruments, and manufacturers
a. The names and locations of manufacturers should be written as follows. When repeating the same manufacturer, omit
		 the city, province/state, and county of origin.
Within the United States: (Manufacturer, city, state abbreviation)
Outside the United States (Manufacturer, city, country)
Only the first letter of each word in the name of the company should be capitalized.
Exception: companies whose name is an acronym.
b. Use common names for chemical substances. If the product name is needed, put it in parentheses.
6.4 Bibliographical citations in the text1) All documents cited in the text should be included in a list.
Only the sources cited in the text should be listed.
2) Indicate citation order in the text with superscript numbers. These should be typed after the period or comma without 				

space. [Example]: ....in the recovery of general health.2§ 7 Acknowledgments
Titles and affiliations should not be abbreviated in the acknowledgments. Start a new line for grant mentions.
§ 8 Conflict of interest
In the case of the absence of conflict of interest, type the following at the end of the main body of text (PMC recommended
wording):
The authors declare no conflict of interest.
§ 9 REFERENCES
See 6.4 above for citations in the text.
9.1 REFERENCES
1) Order references in the order they appear in the text. Should there be more than 6 authors or editors, use et al. for all the		 following contributors.
page 5

YAM Instructions for Authors

2) Put the PubMed PMID/PubMed Central PMCID at the end of the entry when applicable. For references without the above ID, if they 		have a Digital Object Identifier (DOI) or publisher item identifier (pii), put it in reference to MEDLINE / PubMed citation models. [P.13, 		
No.36: Journal article on the Internet][Example]
Kitaura T, Chikumi H, Fujiwara H, Okada K, Hayabuchi T, Nakamoto M, et al. Positive predictive value of true bacteremia according to
the number of positive culture sets in adult patients. Yanago Acta Med. 2014;57:159- 65. PMID: 25901103.
Saarinen T, Fernström L, Brorsson AL, Olinder A.L. Insulin pump therapy is perceived as liberating, but to many it can imply a sense of
the diabetes made visible. European Diabetes Nursing. 2014;11:38-42. DOI: 10.1002/edn.246.
9.2 Abbreviation of journal names
1) Use the abbreviated names used by MEDLINE/PubMed. Do not mix old abbreviations with new ones.
2) Do not abbreviate journal names that consist of one word.
3) Do not follow each abbreviated word by a period. Use a period after the abbreviated name of the journal.
4) The abbreviation for this journal is "Yonago Acta Med."
5) For Japanese journals, do not abbreviate the name and write in roman letters. Add "Japanese" at the end. [ See P.10, No.5:
		

Languages other than English.] When there is an English abstract, add "Japanese with English abstract" at the end.

6) Use the Hepburn system for romanization.
7) Refer to Table 5 on how to romanize Japanese journal names.
9.3 Reference guideline
Follow the MEDLINE/PubMed reference guidelines. See "Sample references" in the appended "International Committee ofMedical Journal Editors (ICMJE): Uniform requirements for manuscripts (URM) submitted to biomedical journals" (P.11-13.)§ 10 Tables
1) Each table should be typed on a separate page with a title and footnote(s). Add consecutive page numbers following
REFERENCES.
2) Do not use vertical ruled lines. Use as little horizontal ruled lines as possible.
3) Tables should fit on a printed page．
		Width should be within 1 column width (82 mm) or within 2 column width + column gap (170 mm).
The vertical length should be within 234 mm, including the lines of explanatory text. Do not use landscape orientation.

4) Use units with numeral data. Avoid repetition.
5) Define abbreviations that are only used in the table in the footnotes. Arrange the definitions in alphabetical order.
[Example]: F, female, M, male, NS, not significant.
6) Type the footnotes below the data section of the table. Footnote symbols should be used in the order below. Do not use
letters or numbers.
			*, †, ‡, §, ||, ¶, **, ††, ‡‡, §§, ||||, ¶¶, . . . (*Do not use Japanese fonts.)

7) When comparing significant differences, show the level by the number of asterisks. In this case, start with the dagger
symbol for the footnotes other than the indication of significant differences.		
[Example]: *P < 0.05, **P < 0.01, ***P < 0.001
8) Use "Table 1, Table 2, Table 3, etc." when referring to tables in the text.
§ 11 Legends for figures
1) Legends should not be typed above or below each figure. Type all the legends together, separately from the figures. Add
consecutive page numbers following References and Table(s).
2) As a general rule, the explanation of symbols should be included in the legend and not in the figure itself.
3) A short title may be attached to the legend of each figure. Use partial sentences to keep the legend short.
4) Define abbreviations that are only used in the figure in the legend. Arrange the definitions in alphabetical order.
page 6

YAM Instructions for Authors

5) The description of the staining method should be at the end of the sentence.
			[Example]: Fig. 1. . . . (periodic acid-Schiff stain).

6) When the scale marker is within the picture, add text such as "Bar = 10 μm" at the end of the legend. Do not show
magnification.
			[Example]: Fig. 2. . . . (hematoxylin and eosin stain). Bar = 5 μm.
§ 12 Figures

1) As a general rule, figures should be submitted in the desired printing size.
		The width should be within 1 column width (82 mm) or within 2 column width + column gap (170 mm), and, if possible,
be small enough to fit in one column. Height should not exceed 234 mm, including the legend. Do not use landscapeorientation unless necessary.

2) Each figure should be on a different page. Photo sequences may be on the same page.
3) If possible, select symbols from the following to use in figures: ● ○ × ■ □		▲ △Characters should be no smaller than 1.0 mm. Try to avoid using characters smaller than 1.2 mm.
Axis title: Titles for the vertical and horizontal axis should be about 10-12 points.

_

Scale: Scale numbers should be about 7-8 points with well-balanced overall proportions.
4) Use clear pictures only. Crop unnecessary parts as much as possible.
5) Include scale markers within photomicrographs. Do not show the original magnification in the legend.
6) Label photographic and figure series with numbers or letters.
7) Use abbreviated form when referring to the figures in the main text. [Example]: Fig. 1, Figs. 2a and b, Figs. 3–6
Use full word when at the beginning of a paragraph or sentence in the main text. [Example]: Figure 1, Figures 2 and 3§ 13 Abbreviations

13.1 General rules
Do not define abbreviations approved for use by this publication.
For the list of approved abbreviations, see Tables 1–4: pp. 9–10.
1) Do not define standard scientific symbols on the first appearance.

			[Example]: Write “Na” and not “sodium (Na).”

2) Use abbreviations for weights and measurements coming after numbers, even on the first appearance.
			[Example]: Write “3 mL” not “3 milliliters (mL).”

3) Follow the International System of Units (Tables 2 and 3) when writing units. Use "mmHg" for blood pressure
measurements.
13.2 Usage policy
While abbreviations are often a great tool to save time, refrain from using them as much as possible.
1) Do not abbreviate short or relatively short words. Do not abbreviate single words. Spell in full words that are only usedonce.
2) If the citation from the reference contains an acronym, do not cite it as it is. Consider the frequency of use in the
manuscript and review the use and non-use of each word.
13.3 TITLE and ABSTRACT
Avoid using abbreviations as much as possible.
13.4 Defining
If most readers are familiar with the term, define in parentheses following the first use.
1) Use the same abbreviations in the ABSTRACT and the text. Define them in both the ABSTRACT and the TEXT．
2) Do not mix the abbreviated and non-abbreviated versions of the same term. Do not spell out an abbreviation you havealready defined. See § 10-5) and § 11-4) for usage in tables and figures.
3) Keep in mind that the meaning of some chemical symbols changes whether they are italicized or not.
4) Follow the rules of Table 4 for statistics symbols.
5) Add an "s" to abbreviations to pluralize them. Do not add an "s" to pluralize abbreviations of units.
Do not use a period after abbreviations except for periods used per convention such as in Latin.
page 7

YAM Instructions for Authors

13.5 Author abbreviation list
Add a list of author abbreviations in the singular at the bottom of the first page of the manuscript. List in alphabeticalorder, not order of appearance. [Do not include abbreviations from Table 1 in the list.][Example]

Abbreviations: CSS, cancer specific survival; DFS, disease-free survival; ECUD, extracorporeal urinary diversion§ 14 E-text and online submission
For electronic submissions, attach the document to an e-mail or use an appropriate medium (such as a CD).
		 Send e-mail submissions to yamed@med.tottori-u.ac.jp
		 For other forms of media, send to Yonago Acta Medica Editorial Office, Tottori University Medical Press,
		 Tottori University Medical Library.
14.1 Digital text and tables
1) One software used		

If the main text (up to references,) tables, and figure legends have all been created in a word processor (such as
Microsoft Word), combine in one document and save under the proper extension.

2) More than one software used		

If the main body of the text was typed in a word processor and the tables were created in a spreadsheet software, save thefiles in their respective software with the proper extension.

		

Tables created with spreadsheet software such as Excel can be imported in the manuscript (after References) and treated as
text. They should fit on one page.

14.2 Figures: Digital format
Do not process graphs and linear diagrams as photographs. Submit an editable original version.
1) If the file is big, divide it and save it under the proper extension. [Example]: Fig 1.pptx, Fig 2.pptx
2) Pictures (black and white, color) may be submitted as jpeg files.
3) When adding romaji to a digital photo, create another layer and place it on the lower left.
4) When adding a scale marker to a digital photo, create another layer and place it on the lower right.
			

Related articles：P.7 § 11-6), P.7 § 12-5).

5) Resolution for digital pictures should be over 260 dpi for black and white and over 300 dpi for color.

<CONTACT>
Yonago Acta Medica Editorial Office
Tottori University Medical Press
86 Nishi-cho,Yonago City,Tottori Pref., 683-8503, Japan
TEL +81-859-38-7541
Email: yamed@med.tottori-u.ac.jp
HP: http://www.lib.tottori-u.ac.jp/yam/yam.html

page 8YAM Instructions for Authors: Appendices【Appendices】

Table 2. SI prefixes, prefix symbols andthe recommended factors they represent

Table 1. List of abbreviations used without defintion in
Yonago Acta Medica
ACTH
ADP
AMP
ATP
ATPase
cAMP
cDNA
DNA
EDTA
EGTA
FAD
FADH2
GDP
GMP
GTP
Hb
HEPES
LD50
ln, loge
log
mRNA
NAD
NAD+
NADH
NADP
NADP+
NADPH
PAGE
PCR
pH
Pi, PPi
pK
polyA
RNA
RNase
rRNA
SD
SDS
SEM, SE
Tris
tRNA
UDP
UMP
UTP
UV

FactorPrefixSymbol

101

deca

da

adrenocorticotrop(h)ic hormone
102
hecto
h
adenosine 5'-diphosphate
3
10
kilo
k
adenosine 5'-monophosphate
106
mega
M			
adenosine 5'-triphosphate
109
giga
G
adenosine triphosphatase
1012
tera
T			
cyclic AMP
15
10
peta
P
complementary DNA
1018
exa
E
deoxyribonucleic acid
10 –1
deci
d
ethylenediaminetetra-acetic acid
10 –2
centi
c
ethyene glycol bis(b-aminoethylether)N,N,N',N,–3
10
milli
m
tetraacetic acid
–6
10
micro
µ
flavin adenine dinucleotide
10 –9
nano
n
reduced form of FAD
–12
10
pico
p
guanosine 5'-diphosphate
10 –15femto
fguanosine 5'-monophosphate
–18
10
atto
a
guanosine 5'-triphosphate
hemoglobin
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acidmedian lethal dose (lethal for 50% of test subjects)
Table 3. SI and relatd units applied in medical
natural logarithm
logarithm
sciences in Yonago Acta Medica
messenger RNA
LENGTHmmeter
nicotinamide-adenine dinucleotide
SURFACE AREA
m2
squaremeteroxidized form of NAD
VOLUMEL
liter
reduced form of NAD
TEMPERATURE°C
degree Celsius
MASS(WEIGHT)ggram
NAD phosphate
TIME
d
day
oxidized form of NADP
		
h
hour
reduced form of NADP		minminutepolyacrylamide gel electrophoresis		ssecondpolymerase chain reaction
POWER
W
watt
ENERGYN
newtonnegative log of hydrogen-ion concentration
		
J
joule
inorganic phosphate, inorganic pyrophosphate
FREQUENCY
Hz
hertz
negative log of dissociation constant
CATALYTIC ACTIVITY
kat
katal
poly(adenylic acid) or polyadenylate
PRESSURE
Pa
pascalribonucleic acid or ribonucleate
SUBSTANCE CONCENTRATION
mol/L
mole per literribonuclease
M
molar
DOSE EQUIVALENT
Sv
sievertribosomal RNA
ABSORVED DOSE
Gygraystandard deviation
ACTIVITY
Bq
becquerel
sodium dodecyl sulfate
EXPOSURE
C/kg
roentgenstandard error of the mean, standard error
OTHER UNITSA
amperetris(hydroxymethyl)aminomethane		bpbase pairtransfer RNA		
bpm
beats per minute		
cpm
counts per minuteuridine 5'-diphosphate		Dadaltonuridine 5'-monophosphate		Kdegree absolute
uridine 5'-triphosphate		eqequivalentultraviolet
		
F
farad
		
		

G
kb

gaus
kilobase (pair)

page 9YAM Instructions for Authors: Appendices

Table 3: continued from the previous page

Table 5. Japanese selections from the list ofjournals indexed for MEDLINE/PubMed users

		
Ω
ohm
		
rpm
revolutions per minute
Arerugi
		S
Svedberg (10–13 s)
Arukoru Kenkyu To Yakubutsu Ison
		
V
volt
Eisei Shikenjo Hokoku
THERMODYNAMIC TERMS
G
Gibbs energy change
Fukuoka Igaku Zasshi		H
enthalpy change
Gan To Kagaku Ryoho		S
entropy change
Hinyokika Kiyo
PHYSICAL AND CHEMICAL
A
absorbanceHokkaido Igaku Zasshi
QUANTITIESgacceleration of gravity
Igaku Kenkyu
		Ddiffusion coefficient
Jikken Dobutsu
		K
equilibrium constantKaibogaku Zasshi
		Km
Michaelis constantKaku Igaku
		ssedimentation
Kansenshogaku Zasshi		ssedimentation coefficient
Kekkaku (Tokyo)t		[a]specific rotation
Kokubyo Gakkai Zasshi
		Mr
relative molecular mass
Kokyu To Junkan		Rfretardation factor
Kyobu Geka
Masui
Nihon Eiseigaku Zasshi
Nippon Ganka Gakkai Zasshi
Nihon Geka Gakkai Zasshi
Nihon Geka Hokan
Nihon Hinyokika Gakkai Zasshi
Table 4. Symbols used in statistics
Nihon Hoigaku Zasshi
Population Sample
Nihon Igaku Hoshasen Gakkai Zasshi
symbolsymbol Explanation
Nihon Ika Daigaku Zasshi
Nihon Jibiinkoka Gakkai Kaiho
F
variance ratio [F-test]		
Nihon Jinzo Gakkai Shi (Tokyo)
H0		
null hypothesis
Nihon Koshu Eisei ZasshiN		
number of subjects (population or lot size)
Nihon Kyobu Geka Gakkai Zasshi
Nihon Kyobu Shikkan Gakkai Zasshinnumber of subjects
Nihon Naibunpi Gakkai ZasshiPprobability of wrongly rejecting the nullNihon Naika Gakkai Zasshi
hypothesis
Nihon Rai Gakkai ZasshiR
coefficient of multiple correlation, range
Nihon Ronen Igakkai Zasshi
of a sample
Nihon Saikingaku Zasshi
Nihon Sanka Fujinka Gakkai Zasshirrcoefficient of correlation
Nihon Seikeigeka Gakkai Zasshissstandard deviation
Nihon Seirigaku Zasshi
s2
s2variance
Nihon Shokakibyo Gakkai Zasshi_
standard error of the mean 		x
Nihon Yakurigaku Zasshitstatistic
derivedinStudent
t-testNo Shinkei Geka__
No To HattatsuXxarithmetic mean
No To Shinkeiaprobability of a type I error; significant
Rinsho Byori
level
Rinsho Ketsuekibprobability of a type II error
Rinsho Shinkeigaku
c2
statistic derived in chi-square test
Ryumachi (Tokyo)
Sangyo Igakuvnumber of degrees of freedom
Sangyo Ika Daigaku Zasshi (Kitakyushu)
Source: Scietific style and format by the CBE manual for authors,
Seikagaku
editors, and publishers. 6th ed. P. 217, Table 11-13.
Seishin Shinkeigaku Zasshi
Shinrigaku Kenkyu
Tanpakushitsu Kakusan Koso
Uirusu (Kyoto)
Yakubutsu, Seishin, Kodo
Yakugaku Zasshispage 10

YAM Instructions for Authors: AppendicesInternational Committee of Medical Journal Editors (ICMJE) Uniform Requirements for Manusripts (URM) Submitted to Biomedical Journals: Sample references
http://www.nlm.nih.gov/bsd/uniform_requirements.html← Please check this website.

Articles in Journals (see also No. 36. Journal article on the Internet)
1. Standard journal article
List the first six authors followed by et al. (Note: NLM now lists all authors.)
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.
As an option, if a journal carries continuous pagination throughout a volume (asmany medical journals do) the month and issue number may be omitted.
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.
More than six authors:
Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding JK, et al.
Regulation of interstitial excitatory amino acid concentrations after cortical contusion
injury. Brain Res. 2002;935:40-6.
Optional addition of a database’s unique identifier for the citation:
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002 Jul 25;347:284-7. PMID: 12140307.
Forooghian F, Yeh S, Faia LJ, Nussenblatt RB. Uveitic foveal atrophy: clinical features
and associations. Arch Ophthalmol. 2009 Feb;127:179-86. PMID: 19204236; PMCID:
PMC2653214.
Optional addition of a clinical trial registration number:Trachtenberg F, Maserejian NN, Soncini JA, Hayes C, Tavares M. Does fluoride incompomers prevent future caries in children? J Dent Res. 2009 Mar;88:276-9. PMID:
19329464. ClinicalTrials.gov registration number: NCT00065988.
2. Organization as author• Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin inparticipants with impaired glucose tolerance. Hypertension. 2002;40:679-86.
3. Both personal authors and organization as author (List all as they appear in the byline.)• Vallancien G, Emberton M, Harving N, van Moorselaar RJ; Alf-One Study Group.
Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms. J Urol. 2003;169:2257-61.
• Margulies EH, Blanchette M; NISC Comparative Sequencing Program, Haussler D,
Green ED. Identification and characterization of multi-species conserved sequences.
Genome Res. 2003 Dec;13:2507-18.
4. No author given• 21st century heart solution may have a sting in the tail. BMJ. 2002;325(7357):184.
5. Article not in English• Ellingsen AE, Wilhelmsen I. Sykdomsangst blant medisin- og jusstudenter. Tidsskr Nor
Laegeforen. 2002;122:785-7. Norwegian.
Optional translation of article title:• Ellingsen AE, Wilhelmsen I. [Disease anxiety among medical students and law students]. Tidsskr Nor Laegeforen. 2002 20;122:785-7. Norwegian.
6. Volume with supplement• Geraud G, Spierings EL, Keywood C. Tolerability and safety of frovatriptan with shortand long-term use for treatment of migraine and in comparison with sumatriptan. Headache. 2002;42 Suppl 2:S93-9.
7. Issue with supplement• Glauser TA. Integrating clinical trial data into clinical practice. Neurology. 2002;58(12Suppl 7):S6-12.
8. Volume with part
• Abend SM, Kulish N. The psychoanalytic method from an epistemological viewpoint.
Int J Psychoanal. 2002;83(Pt 2):491-5.
9. Issue with part
• Ahrar K, Madoff DC, Gupta S, Wallace MJ, Price RE, Wright KC. Development of alarge animal model for lung tumors. J Vasc Interv Radiol. 2002;13(9 Pt 1):923-8.
10. Issue with no volume• Banit DM, Kaufer H, Hartford JM. Intraoperative frozen section analysis in revision
total joint arthroplasty. Clin Orthop. 2002;(401):230-8.
11. No volume or issue• Outreach: bringing HIV-positive individuals into care. HRSA Careaction. 2002 Jun:1-6.

page 11

YAM Instructions for Authors: Appendices

ICMJE URM: Sample references, continued from the previous page
12. Pagination in roman numerals• Chadwick R, Schuklenk U. The politics of ethical consensus finding. Bioethics. 2002;16(2):iii-v.
13. Type of article indicated as needed• Tor M, Turker H. International approaches to the prescription of
long-term oxygen therapy [letter]. Eur Respir J. 2002;20(1):242.
• Lofwall MR, Strain EC, Brooner RK, Kindbom KA, Bigelow
GE. Characteristics of older methadone maintenance (MM)patients [abstract]. Drug Alcohol Depend. 2002;66 Suppl 1:S105.

• American Occupational Therapy Association, Ad Hoc Committee on Occupational Therapy Manpower. Occupational therapy
manpower: a plan for progress. Rockville (MD): The Association; 1985 Apr. 84 p.
• National Lawyer’s Guild AIDs Network (US); National Gay
Rights Advocates (US). AIDS practice manual: a legal and educational guide. 2nd ed. San Francisco: The Network; 1988.
23. Chapter in a book
• Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations
in human solid tumors. In: Vogelstein B, Kinzler KW, editors.
The genetic basis of human cancer. New York: McGraw-Hill;
2002. p. 93-113.

14. Article containing retraction• Feifel D, Moutier CY, Perry W. Safety and tolerability of a
rapidly escalating dose-loading regimen for risperidone. J Clin
Psychiatry. 2002;63(2):169. Retraction of: Feifel D, Moutier CY, 24. Conference proceedings• Harnden P, Joffe JK, Jones WG, editors. Germ cell tumours V.
Perry W. J Clin Psychiatry. 2000;61(12):909-11.
Proceedings of the 5th Germ Cell Tumour Conference; 2001 Sep
Article containing a partial retraction: [Added 12 May 2009]13-15; Leeds, UK. New York: Springer; 2002.
• Starkman JS, Wolder CE, Gomelsky A, Scarpero HM, Dmochowski RR. Voiding dysfunction after removal of eroded slings. 25. Conference paper
J Urol. 2006 Dec;176(6 Pt 1):2749. Partial retraction of: Starkman• Christensen S, Oppacher F. An analysis of Koza’s computationalJS, Wolter C, Gomelsky A, Scarpero HM, Dmochowski RR. J
effort statistic for genetic programming. In: Foster JA, Lutton
Urol. 2006 Sep;176(3):1040-4.
E, Miller J, Ryan C, Tettamanzi AG, editors. Genetic programming. EuroGP 2002: Proceedings of the 5th European Confer15. Article retracted
ence on Genetic Programming; 2002 Apr 3-5; Kinsdale, Ireland.
• Feifel D, Moutier CY, Perry W. Safety and tolerability of a
Berlin: Springer; 2002. p. 182-91.
rapidly escalating dose-loading regimen for risperidone. J Clin
Psychiatry. 2000;61(12):909-11. Retraction in: Feifel D, Moutier 26. Scientific or technical report
CY, Perry W. J Clin Psychiatry. 2002;63(2):169.
Issued by funding/sponsoring agency:
Article partially retracted: [Added 12 May 2009]• Yen GG (Oklahoma State University, School of Electrical and• Starkman JS, Wolter C, Gomelsky A, Scarpero HM, DmoComputer Engineering, Stillwater, OK). Health monitoring onchowski RR. Voiding dysfunction following removal of eroded
vibration signatures. Final report. Arlington (VA): Air Force Ofsynthetic mid urethral slings. J Urol. 2006 Sep;176(3):1040fice of Scientific Research (US), Air Force Research Laboratory;
4. Partial retraction in: Starkman JS, Wolder CE, Gomelsky
2002 Feb. Report No.: AFRLSRBLTR020123. Contract No.:A, Scarpero HM, Dmochowski RR. J Urol. 2006 Dec;176(6 Pt
F496209810049.
1):2749.
Issued by performing agency:
16. Article republished with corrections• Mansharamani M, Chilton BS. The reproductive importance ofP-type ATPases. Mol Cell Endocrinol. 2002;188(1-2):22-5. Corrected and republished from: Mol Cell Endocrinol. 2001;183(12):123-6.

• Russell ML, Goth-Goldstein R, Apte MG, Fisk WJ. Method formeasuring the size distribution of airborne Rhinovirus. Berkeley (CA): Lawrence Berkeley National Laboratory, Environmental Energy Technologies Division; 2002 Jan. Report No.:
LBNL49574. Contract No.: DEAC0376SF00098. Sponsored by
the Department of Energy.

17. Article with published erratum• Malinowski JM, Bolesta S. Rosiglitazone in the treatmentof type 2 diabetes mellitus: a critical review. Clin Ther.
2000;22(10):1151-68; discussion 1149-50. Erratum in: Clin Ther.
2001;23(2):309.

27. Dissertation• Borkowski MM. Infant sleep and feeding: a telephone survey of
Hispanic Americans [dissertation]. Mount Pleasant (MI): Central Michigan University; 2002.

18. Article published electronically ahead of the print version• Yu WM, Hawley TS, Hawley RG, Qu CK. Immortalization of yolk sac-derived precursor cells. Blood. 2002 Nov
15;100(10):3828-31. Epub 2002 Jul 5.

28. Patent• Pagedas AC, inventor; Ancel Surgical R&D Inc., assignee. Flexible endoscopic grasping and cutting device and positioning tool
assembly. United States patent US 20020103498. 2002 Aug 1.

Books and Other Monographs

Other Published Material

19. Personal author(s)• Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical
microbiology. 4th ed. St. Louis: Mosby; 2002.

29. Newspaper article• Tynan T. Medical improvements lower homicide rate: study seesdrop in assault rate. The Washington Post. 2002 Aug 12;Sect. A:2(col. 4).

20. Editor(s), compiler(s) as author• Gilstrap LC 3rd, Cunningham FG, VanDorsten JP, editors. Operative obstetrics. 2nd ed. New York: McGraw-Hill; 2002.

30. Audiovisual material• Chason KW, Sallustio S. Hospital preparedness for bioterrorism[videocassette]. Secaucus (NJ): Network for Continuing Medical
Education; 2002.

21. Author(s) and editor(s)• Breedlove GK, Schorfheide AM. Adolescent pregnancy. 2nd ed.
Wieczorek RR, editor. White Plains (NY): March of Dimes Edu- 31. Legal Material
cation Services; 2001.
Public law:
• Veterans Hearing Loss Compensation Act of 2002, Pub. L. No.
22. Organization(s) as author
107-9, 115 Stat. 11 (May 24, 2001).
• Advanced Life Support Group. Acute medical emergencies: thepractical approach. London: BMJ Books; 2001. 454 p.

page 12YAM Instructions for Authors: Appendices

Unenacted bill:• Healthy Children Learn Act, S. 1012, 107th Cong., 1st Sess.
(2001).
Code of Federal Regulations:• Cardiopulmonary Bypass Intracardiac Suction Control, 21 C.F.R.
Sect. 870.4430 (2002).
Hearing:• Arsenic in Drinking Water: An Update on the Science, Benefits
and Cost: Hearing Before the Subcomm. on Environment, Technology and Standards of the House Comm. on Science, 107th
Cong., 1st Sess. (Oct. 4, 2001).
32. Map• Pratt B, Flick P, Vynne C, cartographers. Biodiversity hotspots[map]. Washington: Conservation International; 2000.
33. Dictionary and similar references• Dorland’s illustrated medical dictionary. 29th ed. Philadelphia:
W.B. Saunders; 2000. Filamin; p. 675.

Unpublished Material
34. In press or Forthcoming (Note: NLM prefers “Forthcoming” rather than “In press” because not all items will be printed.)• Tian D, Araki H, Stahl E, Bergelson J, Kreitman M. Signatureof balancing selection in Arabidopsis. Proc Natl Acad Sci U S A.
Forthcoming 2002.

Electronic Material
35. CD-ROM• Anderson SC, Poulsen KB. Anderson’s electronic atlas ofhematology [CD-ROM]. Philadelphia: Lippincott Williams &Wilkins; 2002.
36. Journal article on the Internet• Abood S. Quality improvement initiative in nursing homes: the
ANA acts in an advisory role. Am J Nurs [Internet]. 2002 Jun[cited 2002 Aug 12];102(6):[about 1 p.]. Available from: http://
www.nursingworld.org/AJN/2002/june/Wawatch.htmArticle
Optional presentation (omits bracketed phrase that qualifies
the journal title abbreviation):• Abood S. Quality improvement initiative in nursing homes: the
ANA acts in an advisory role. Am J Nurs. 2002 Jun [cited 2002
Aug 12];102(6):[about 1 p.]. Available from: http://www.nursingworld.org/AJN/2002/june/Wawatch.htmArticle
Article published on the Internet ahead of the print version:
See # 18.
Optional formats used by NLM in MEDLINE/PubMed:
Article with document number in place of traditional pagination:• Williams JS, Brown SM, Conlin PR. Videos in clinical medicine. Blood-pressure measurement. N Engl J Med. 2009 Jan
29;360(5):e6. PMID: 19179309.
Article with a Digital Object Identifier (DOI):• Zhang M, Holman CD, Price SD, Sanfilippo FM, Preen DB,
Bulsara MK. Comorbidity and repeat admission to hospitalfor adverse drug reactions in older adults: retrospective cohort
study. BMJ. 2009 Jan 7;338:a2752. doi: 10.1136/bmj.a2752.
PMID: 19129307; PMCID: PMC2615549.
Article with unique publisher item identifier (pii) in place oftraditional pagination or DOI:
• Tegnell A, Dillner J, Andrae B. Introduction of human papillomavirus (HPV) vaccination in Sweden. Euro Surveill. 2009 Feb
12;14(6). pii: 19119. PMID: 19215721.

37. Monograph on the Internet• Foley KM, Gelband H, editors. Improving palliative carefor cancer [Internet]. Washington: National Academy Press;
2001 [cited 2002 Jul 9]. Available from: http://www.nap.edu/books/0309074029/html/.
38. Homepage/Web site
• Cancer-Pain.org [Internet]. New York: Association of Cancer
Online Resources, Inc.; c2000-01 [updated 2002 May 16; cited
2002 Jul 9]. Available from: http://www.cancer-pain.org/.
39. Part of a homepage/Web site
• American Medical Association [Internet]. Chicago: The Association; c1995-2002 [updated 2001 Aug 23; cited 2002 Aug
12]. AMA Office of Group Practice Liaison; [about 2 screens].
Available from: http://www.ama-assn.org/ama/pub/category/1736.html
40. Database on the Internet
Open database:• Who’s Certified [Internet]. Evanston (IL): The American Boardof Medical Specialists. c2000 -   [cited 2001 Mar 8]. Available
from: http://www.abms.org/newsearch.asp
Closed database:• Jablonski S. Online Multiple Congenital Anomaly/Mental
Retardation (MCA/MR) Syndromes [Internet]. Bethesda (MD):National Library of Medicine (US); c1999 [updated 2001 Nov
20; cited 2002 Aug 12]. Available from: http://www.nlm.nih.
gov/archive//20061212/mesh/jablonski/syndrome_title.html
41. Part of a database on the Internet• MeSH Browser [Internet]. Bethesda (MD): National Libraryof Medicine (US); 2002 -   . Meta-analysis [cited 2008 Jul
24]; [about 2 p.]. Available from: http://www.nlm.nih.gov/cgi/
mesh/2008/MB_cgi?mode=&index=16408&view=concept
MeSH Unique ID: D017418.
42. Blogs [Added 12 May 2009]• Holt M. The Health Care Blog [Internet]. San Francisco: Matthew Holt. 2003 Oct -   [cited 2009 Feb 13]. Available from:http://www.thehealthcareblog.com/the_health_care_blog/.
• KidneyNotes.com [Internet]. New York: KidneyNotes. c2006 -  [cited 2009 Feb 13]. Available from: http://www.kidneynotes.
com/.
• Wall Street Journal. HEALTH BLOG: WSJ’s blog on healthand the business of health [Internet]. Hensley S, editor. New
York: Dow Jones & Company, Inc. c2007 -   [cited 2009 Feb
13]. Available from: http://blogs.wsj.com/health/.

Contribution to a blog:• Mantone J. Head trauma haunts many, researchers say. 2008
Jan 29 [cited 2009 Feb 13]. In: Wall Street Journal. HEALTHBLOG [Internet]. New York: Dow Jones & Company, Inc.
c2008 -   . [about 1 screen]. Available from: http://blogs.wsj.
com/health/2008/01/29/head-trauma-haunts-many-researcherssay/.
• Campbell A. Diabetes and alcohol: do the two mix? (Part 2).
2008 Jan 28 [cited 2009 Feb 13]. In: Diabetes Self-Management
Blog [Internet]. New York: Diabetes Self-Management. [2006Aug 14] -   . 2 p. Available from: http://www.diabetesselfmanagement.com/blog/Amy_Campbell/Diabetes_and_Alcohol_
Do_the_Two_Mix_Part_2• Reider J. Docnotes: Health, Technology, Family Medicine andother observations [Internet]. [place unknown]: Jacob Reider.
1999 -   . CRP again ...; 2004 Apr 2 [cited 2009 Feb 13]; [about
1 screen]. Available from: http://www.docnotes.com/2004/04/
crp-again.html

page 13

YAM Instructions for Authors: Appendices

ICMJEForm
FormforforDisclosure
DisclosureofofPotential
PotentialConflicts
ConflictsofofInterest
Interest
ICMJE
http://www.icmje.org/conflicts-of-interest/ ← Please conduct a self-check for the status of conflicts of interest (COI) via this website.
The abstract form is below.

Section 1. Identifying information

Section 4. Interectual Property -- Patents & Copyrights

1. Given Name (First Name)

Do you have any patents, whether planned, pending or issued,

2. Surname (Last Name)

broadly relevant to the work? □ Yes □ No

3. Date4. Are you the corresponding author? □ Yes □ No

Section 5. Relationships not covered above

5. Mabuscript Title

Are there other relationships or activities that readers could perceive

6. Manuscript Identifying Number (if you know it)

to have influenced, or that give the appearance of potentiallyinfluencing, what you wrote in the submitted work?

Section 2. The Work Under Consideration for Publication
Did you or your institution at any time receive payment or services□ Yes, the following relationships/conditions/circumstances arepresent (explain below):□ No other relationships/conditions/circumstances that present a
potential conflict of interestetc.) for any aspect of the submitted work (including but not limited
from a third party (government, commercial, private foundation,
to grants, data monitoring board, study design, manuscript
preparation, statistical analysis, etc.)? Are there any relevant

Section 6. Disclosure Statement

conflicts of interest? □ Yes □ No

Based on the above disclosures, this form will automaticallygenerate a disclosure statement, which will appear in the box

Section 3. Relevant financial activities outside the submitted

below.

work

Generate Disclosure Statement

Place a check in the appropriate boxes in the table to indicate
whether you have financial relationships (regardless of amountof compensation) with entities as described in the instructions. Use
one line for each entity; add as many lines as you need byclicking the "Add +" box. You should report relationships that were
present during the 36 months prior to publication. Are there any
relevant conflicts of interest? □ Yes □ No

Code of Ethics
・ If the content of the dissertation is a clinical study, informed consent from the subject and approval of the research plan by the Institutional
Ethics Committee (or equivalent) have been obtained, the authorization number must be included in the text. Also, it should be stated in the
text that research requiring the approval of the ethics committee, such as observational research (information, samples, etc.), has been approved. Also, include the authorization number in the text. However, in the case of a simple patient report, the number is not necessary unlessthe said report includes statistical processing, etc. In the case of animal experiments, include in the text the Animal Care and Use Committee's
authorization number, which confirms that the research is compliant with the guidelines.
・ If the content of the article is based on a clinical trial, it must be registered in a clinical trial registration system that meets the criteria of theInternational Committee of Medical Journal Editors (ICMJE) such as UMIN-CTR. Specify in the text that registration has been completed,
and include the authorization number in the text.
・ If research included administration of an unapproved drug or unapproved medical technology, it should be stated in the text. Also, when using
drugs that may cause adverse side effects, such as antineoplastic drugs, indicate in the text, together with the authorization number, that they
have been reviewed by an appropriate ethics committee.
・Comply with the Personal Information Protection Act when handling personal information. Especially in case reports and clinical research,
describe the clinical course so that it may be identified without specifying the name, date of birth, and dates such as the date of implementation to ensure that individuals are not identified and their privacy is protected.

page 14

YAM Instructions for Authors: Appendices
添え状

編集長への covering letter について
原稿はオンライン投稿＊で受け付けます. 投稿時・改定時に編集長宛のカバーレターをメール本文へお書き下さい .
特殊フォント使用の場合は、ワード書類などとして添付下さい . できれば和文でお書き下さい [ 英文でもよい ].

＊原稿の電子テキスト ( 本文・図・表 ) を電子メールへ添付し編集担当へ送信する . 編集委員長宛とする .

以下の例は学位申請予定論文の場合です.
学位申請予定論文は、投稿者が査読者を 2 名指名することができます. 主査、副査を査読者として指名することも可能です. ただし、必ずしも指名者が査読者に決定するとは限りません . また、投稿者が査読者の指名を希望しない場合は、編集委員会にて選定を行います.（副論文の場合、査読者の指名はできません .）						[ ご注意 ]
					
					
					

共著者へは査読依頼できない事になっています.
共著者は主査にはなれません . 共著者は副査にはなれます.
当誌では著者と同じ所属の研究者へは原則として査読依頼致しません .
詳細は学務課へお尋ね下さい .

投稿時
Yonago Acta Medica 編集長○○教授殿
挨拶など（簡単に）論題、著者名を明記する .
論文の新知見について簡潔に記す .
COI の有無を記す .
（学位審査用の申請の場合）
当論文は、××の学位論文として申請する予定ですので 査読者として主査▲▲教授並びに副査◆◆教授を希望します .
または当論文は、××の学位論文として申請する予定ですので 査読者として副査★★教授と◆◆教授を希望します .
		
		
		

主査
副査
副査

▲▲教授 （・・分野）★★教授 （・・分野）◆◆教授 （・・分野）

日 付
所 属
×× ( 著者名 )改訂時

査読者 2 名 (Referees A and B) からの査読回答書に対する著者のコメントを 編集長宛にまとめる．

Yonago Acta Medica 編集長○○教授殿
挨拶など（簡単に）
先日投稿いたしました論文 "A Study on ..." について査読回答書を頂きましたので、指示に従い改訂しました .
査読回答へ番号を振り、番号順に point-by-point responseで
返答 / 修正を書く
改訂稿を再投稿いたします. 改訂稿では、Referee A 回答に対する返答 / 修正を赤色テキスト、
Referee Ｂ回答に対する返答 / 修正を青色テキストと色分けしています.
宜しくお願いします・・など .
日 付
所 属×× ( 著者名 )モニタ上で原稿チェックをするようになっていますので改訂箇所等を彩色して下さい

page 15